Grantors:

Lilly US, LLC Novartis Pharmaceuticals CorporationGenomic Health

Scroll to the Bottom of this Information to Begin this Course

Target Audience

This webcast is directed primarily to hematologists/oncologists, radiation oncologists, surgical oncologists, pathologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new developments for treatment of lung and breast cancers. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Statement of Need/Program Overview

This webcast is intended to improve care of patients with lung and breast cancers by accelerating adoption of new guidelines and evidence-based practice change. In addition to chemotherapy and targeted therapy of lung and breast cancers, this symposium will focus on individualized treatment options. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.